OptimizeRx improves profitability with $21.6 million in Q3 revenue
OPRX OptimizeRx Corp
$8.95 -4.28%
View chart & analysis → - 1OptimizeRx recorded $21.6 million in revenue for the third quarter of 2026.
- 2OptimizeRx revenue decreased by 17% in the third quarter, but the adjusted EBITDA margin was approximately 29%.
- 3Stephen Silvestro updated the 2026 annual revenue guidance to a range of $87 million to $93 million.
So what's the key point?
OptimizeRx recorded $21.6 million in revenue for the third quarter. While revenue fell by 17%, the profit margin was approximately 29%.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.